Elekta
Develops precision radiation medicine solutions for treating cancer and brain disorders.
EKTA | ST
Overview
Corporate Details
- ISIN(s):
- SE0000163628 (+12 more)
- LEI:
- 54930044O54BK617EP80
- Country:
- Sweden
- Address:
- Box 7593, 103 93 Stockholm
- Website:
- https://www.elekta.com/
- Sector:
- Manufacturing
Description
Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-11-19 07:30 |
South Korea’s Yonsei University Health System orders four Elekta radiation ther…
|
English | 114.5 KB | ||
| 2013-10-31 18:00 |
Antalet utestående aktier i Elekta AB (publ)
|
Swedish | 14.7 KB | ||
| 2013-10-31 18:00 |
Number of outstanding shares in Elekta AB (publ)
|
English | 54.7 KB | ||
| 2013-10-25 07:30 |
Niklas Savander utsedd till Elektas nästa vd och koncernchef
|
Swedish | 66.3 KB | ||
| 2013-10-25 07:30 |
Elekta appoints Niklas Savander as its next President and Chief Executive Offic…
|
English | 155.4 KB | ||
| 2013-10-22 12:00 |
Elekta declines to continue to participate in linear accelerator bidding proces…
|
English | 66.8 KB | ||
| 2013-10-22 12:00 |
Elekta avböjer fortsatt deltagande i brasiliansk anbudsprocess på linjäracceler…
|
Swedish | 58.1 KB | ||
| 2013-10-16 13:45 | English | 33.9 KB | |||
| 2013-10-02 07:30 |
Klartecken i USA för Esteya - Elektas nya system för hudcancer
|
Swedish | 60.8 KB | ||
| 2013-10-02 07:30 |
Nucletron, an Elekta Company, Receives US FDA 510(k) Clearance for Esteya Elect…
|
English | 72.3 KB | ||
| 2013-09-23 15:00 |
Elekta leads radiation therapy industry through innovation
|
English | 119.6 KB | ||
| 2013-09-23 15:00 |
Elekta öppnar utbildningscenter inom onkologi och neurovetenskap
|
Swedish | 68.6 KB | ||
| 2013-09-21 18:00 |
Elekta lanserar Esteya – elektronisk brachyterapi för behandling av hudcancer
|
Swedish | 104.2 KB | ||
| 2013-09-21 18:00 |
Nucletron, an Elekta Company, Introduces Esteya, Electronic Brachytherapy for T…
|
English | 81.6 KB | ||
| 2013-09-18 13:00 |
Elekta inkluderas i Dow Jones Sustainability Index
|
Swedish | 21.4 KB |
Automate Your Workflow. Get a real-time feed of all Elekta filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Elekta
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Elekta via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-16 | Maurits Wolleswinkel | Other | Buy | 9,000 | 558,000.00 SEK |
| 2024-09-16 | Caroline Cooke | Other | Sell | 7,250 | 471,250.00 SEK |
| 2024-06-07 | Caroline Cooke | Other | Other | 72,000 | N/A |
| 2024-01-04 | Anna Conneryd Lundgren | Other | Buy | 1,546 | 130,018.60 SEK |
| 2024-01-03 | Anna Conneryd Lundgren | Other | Buy | 1,300 | 109,590.00 SEK |
| 2023-07-18 | Tobias Hägglöv | Other | Buy | 2,700 | 226,233.00 SEK |
| 2023-07-03 | Gustaf Nils Philip Salford | Other | Buy | 6,000 | 501,420.00 SEK |
| 2023-01-02 | Cecilia Wikström | Other | Buy | 1,000 | 63,340.00 SEK |
| 2022-09-16 | Verena Schiller | Other | Buy | 5,100 | 27,846.00 EUR |
| 2022-09-15 | Andrew Wilson | Other | Buy | 400 | 2,180.00 USD |
Peer Companies
